4/5/2016 | BK | Market Commentary: Diebold, Alvogen, Blount break; Valeant rises; MGM Growth Properties deal updates surface
|
3/30/2016 | BK | Market Commentary: Valeant rises with amendment; Western Digital breaks; Blount, DYK Automotive changes surface
|
3/29/2016 | BK | Market Commentary: TierPoint frees up; Western Digital revises pricing; TruGreen Holdings sets price talk
|
4/2/2015 | BK | Alvogen upsizes term loan to $700 million, revises OID to 99˝
|
3/19/2015 | BK | Moody’s rates Alvogen CFR, loan B3
|
3/17/2015 | BK | Market Commentary: American Beacon, E.W. Scripps free to trade; Regal Cinemas term loan gains on refinancing
|
11/8/2013 | BK | Alvogen Pharma increases add-on term loan B amount to $70 million
|
11/8/2013 | BK | Market Commentary: Terex, KIK Custom Products, Alvogen break; Arby's, CSC ServiceWorks revisions emerge
|
11/7/2013 | BK | Alvogen Pharma sets discount on $60 million add-on term B at 981/2
|
11/7/2013 | BK | Market Commentary: Crosby, Northeast Wind, Active Network break; primary busy with deal changes and launches
|
11/5/2013 | BK | Alvogen Pharma launches $60 million add-on term B at 98 to 981/2 OID
|
11/5/2013 | BK | Market Commentary: Virtu Financial breaks; Crosby Worldwide, Ascensus, Sandy Creek Energy Associates rework deals
|
11/1/2013 | BK | Alvogen Pharma to launch $60 million add-on term loan B on Tuesday
|
11/1/2013 | BK | Market Commentary: Greenway, Town Sports, Microsemi break; Blackboard B-2 dips; Garda, Vince, Genesys reworked
|
5/15/2013 | BK | Alvogen upsizes term loan to $240 million, tightens discount talk to 99
|
5/15/2013 | BK | Market Commentary: Blue Coat, Crestwood, Houghton Mifflin set talk; Alvogen Pharma upsizes; NCI sets bank meeting
|
4/30/2013 | BK | Alvogen Pharma launches $225 million term loan B at Libor plus 575 bps
|
4/30/2013 | BK | S&P rates Alvogen loan B-
|
4/30/2013 | BK | Moody's rates Alvogen loan B3
|
4/30/2013 | BK | Market Commentary: SourceHOV, HCA, Harden Healthcare, ThermaSys, Virtu, National CineMedia break into secondary
|
4/26/2013 | BK | Market Commentary: Harland Clarke, Focus Brands, Caraustar break; SuperMedia term loan dips with numbers
|
4/26/2013 | BK | Alvogen Pharma to launch $225 million term loan B on Tuesday
|